RxDoctor Payments Data

Jill Nielsen

Nurse Practitioner · Blairsville, GANPI 1962503730

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $30,475 of the $38,343 with a category attached, or 79.5%. Medtronic accounts for 80.0% of it on its own, with 45 other manufacturers making up the rest. Reporting peaked in 2023 at $11,978 and has fallen 56.7% since, to $5,190 in 2025. Among nurse practitioner clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$38,343in general payments, 2019–2025

Across 350 payments — averaging $109.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$31K
  • Amgen$971
  • Novo Nordisk$818
  • Corcept Therapeutics$803
  • Radius Health, Inc.$404
  • AstraZeneca$402
  • plus $4K from 40 others

What the payments were for

  • Speaking & faculty fees$30,47579%
  • Food & beverage$7,85720%
  • Education$110%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$38,343 in reported general payments places this provider in the 95th percentile of 3,328 nurse practitioner providers in Georgia.

See all nurse practitioner providers in Georgia

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide127$265,724
OzempicSemaglutide148$252,853
TrulicityDulaglutide86$143,891
JardianceEmpagliflozin96$136,385
Tresiba Flextouch U-200Insulin Degludec64$87,384
EliquisApixaban59$66,645
SymtuzaDarunavir/Cob/Emtri/Tenof Alaf12$55,576
TivicayDolutegravir Sodium12$53,313
GemtesaVibegron46$38,982
LinzessLinaclotide29$32,517
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$19,455
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog15$19,175
Breztri AerosphereBudesonide/Glycopyr/Formoterol16$17,401
VascepaIcosapent Ethyl17$16,994
Tresiba Flextouch U-100Insulin Degludec16$16,420

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity, Humalog$364$420,242246 claims
Novo NordiskOzempic, Novolog$818$266,270174 claims
Boehringer IngelheimJardiance$262$136,38596 claims
PfizerEliquis$280$66,64559 claims
Sumitomo Pharma America, Inc.Gemtesa$177$38,98246 claims
AbbVieLinzess, Synthroid$308$35,55795 claims
GSKTrelegy Ellipta, Breo Ellipta$277$31,56340 claims
AstraZenecaBreztri Aerosphere, Farxiga$402$28,55331 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$115$11,98211 claims
Astellas Pharma US IncMyrbetriq$23$6,85014 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,328 nurse practitioner providers in Georgia.

Other nurse practitioner in Blairsville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →